| |
Received LUM/IVA
|
Not received LUM/IVA
| |
|---|
|
Number
|
10
|
10
| |
|
Age (range) years
|
26.5 (19–56)
|
30.6 (24–47)
|
P = 0.9
|
|
Sex M:F
|
6:4
|
5:5
| |
|
BMI
|
21.5 (3.3)
|
21.8 (3.0)
|
P = 0.8
|
|
FEV1% predicted
|
36.3 (2.8)
|
40.1 (6.6)
|
P = 0.1
|
|
Range
|
(32.4–40.1)
|
(32.1–44.3)
|
|
FVC% predicted
|
66.4 (12.2)
|
66.5 (12.2)
|
P = 0.8
|
|
Range
|
(51.4–77.2)
|
(50.8–76.5)
|
|
TLC (% predicted)
|
98.11 (16)
|
95.7 (1.4)
|
P = 0.8
|
|
FRC (% predicted)
|
122 (36.3)
|
124 (15.1)
|
P = 0.8
|
|
RV (% predicted)
|
200.4 (69.6)
|
198 (53)
|
P = 0.7
|
|
DLCO (% predicted)
|
58 (14.6)
|
63 (18.2)
|
P = 0.6
|
|
6 MWT m
|
532.4 (90.1)
|
546 (81.3)
|
P = 0.8
|
|
CF related diabetes
|
5
|
5
| |
|
Pseudomonas
|
9
|
9
| |
|
Burkholderia Cenocepacia
|
1
|
1
| |
|
Number of exacerbations in the previous 12 months requiring IV antibiotics
|
3 (4.6)
|
2.8 (5.6)
|
P = 0.8
|
|
Using regular nebulised DNase
|
10
|
10
|
NA
|
|
Using regular Azithromycin
|
8
|
9
|
P = 0.9
|
|
Using regular nebulised antibiotics
|
9
|
9
|
P = 0.8
|
